Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I Diabetes

This study is not yet open for participant recruitment.
Verified June 2011 by Soroka University Medical Center
Sponsor:
Collaborator:
Clalit Health Services
Information provided by:
Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT01382459
First received: June 23, 2011
Last updated: June 24, 2011
Last verified: June 2011

June 23, 2011
June 24, 2011
July 2011
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01382459 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I Diabetes
The Efficacy of Constructed Intervention by Home and School Visits by Diabetes Nurses on Diabetic Control of Children With Type I Diabetes

The investigators assume that an intervention program that includes home visits and trainings of diabetes' nurse and dietitian will lead to an improvement of the patients' metabolic balance, a decrease in complications' rate, a reduction of hospitalizations and an economic streamlining.

The investigators assume that during the study, subjects from the intervention group will reach a better metabolic balance than the control group. In this group the following changes will occur:

  • A decrease in HbA1C levels.
  • A decrease in Hypoglycemia events.
  • A decrease in DKA events.
  • A decrease in patients' visits in ER and hospitalizations.
  • An improvement in the knowledge of the patients and their families about the disease.
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

type 1 DM children in the age of 4-18, living in Beer Sheva and the area, who are under treatment in the pediatric diabetes unit in Soroka.

Type 1 Diabetes Mellitus
Not Provided
  • type 1 DM children- intervention group
    will have home visits and trainings at school
  • type 1 DM children- control group
    will receive the standard care at the clinic
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
100
Not Provided
Not Provided

Inclusion Criteria:

  • Type 1 DM diagnosis from at least 8 months/
  • HbA1C levels >8
  • Signed inform consent.

Exclusion Criteria:

- Children who are not in educational settings and are not hebrew or arabic speakers.

Both
4 Years to 18 Years
No
Contact: Eli Hershkovitz, PI 972- 522629025 elih@bgu.ac.il
Contact: Addi Maabari, S.C 972-547280902 adimaa@clalit.org.il
Israel
 
NCT01382459
sor517111ctil
Yes
Prof. Eli Hershkovitz, Pediatric endocrinology and diabetes unit
Soroka University Medical Center
Clalit Health Services
Not Provided
Soroka University Medical Center
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP